144 related articles for article (PubMed ID: 34688791)
1. Mechanistic physicochemical insights into glycation and drug binding by serum albumin: Implications in diabetic conditions.
Ghosh R; Kishore N
Biochimie; 2022 Feb; 193():16-37. PubMed ID: 34688791
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
Tramarin A; Naldi M; Degani G; Lupu L; Wiegand P; Mazzolari A; Altomare A; Aldini G; Popolo L; Vistoli G; Przybylski M; Bartolini M
Anal Bioanal Chem; 2020 Jul; 412(18):4245-4259. PubMed ID: 32367292
[TBL] [Abstract][Full Text] [Related]
3. Influence of Piracetam on Gliclazide-Glycated Human Serum Albumin Interaction. A Spectrofluorometric Study.
Szkudlarek A; Pożycka J; Maciążek-Jurczyk M
Molecules; 2018 Dec; 24(1):. PubMed ID: 30597970
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Investigation of the Interaction of Tolbutamide and Losartan with Human Serum Albumin in Hyperglycemia States.
Szkudlarek A; Pentak D; Ploch A; Pożycka J; Maciążek-Jurczyk M
Molecules; 2017 Dec; 22(12):. PubMed ID: 29258218
[TBL] [Abstract][Full Text] [Related]
5. Studies of binding by sulfonylureas with glyoxal- and methylglyoxal-modified albumin by immunoextraction using affinity microcolumns.
Rodriguez EL; Tao P; Woolfork AG; Li Z; Matsuda R; Sun Z; Hage DS
J Chromatogr A; 2021 Feb; 1638():461683. PubMed ID: 33223150
[TBL] [Abstract][Full Text] [Related]
6. Methylglyoxal induced glycation and aggregation of human serum albumin: Biochemical and biophysical approach.
Ahmed A; Shamsi A; Khan MS; Husain FM; Bano B
Int J Biol Macromol; 2018 Jul; 113():269-276. PubMed ID: 29481950
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of colchicine on albumin glycation and cellular oxidative stress: Insights into diabetic cardiomyopathy.
Thakur MR; Tupe RS
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23664. PubMed ID: 38372178
[TBL] [Abstract][Full Text] [Related]
8. Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide.
Gajahi Soudahome A; Catan A; Giraud P; Assouan Kouao S; Guerin-Dubourg A; Debussche X; Le Moullec N; Bourdon E; Bravo SB; Paradela-Dobarro B; Álvarez E; Meilhac O; Rondeau P; Couprie J
J Biol Chem; 2018 Mar; 293(13):4778-4791. PubMed ID: 29414771
[TBL] [Abstract][Full Text] [Related]
9. Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus.
Mariee AD; Al-Shabanah O
J Pharm Biomed Anal; 2006 May; 41(2):571-5. PubMed ID: 16469467
[TBL] [Abstract][Full Text] [Related]
10. Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns.
Tao P; Li Z; Matsuda R; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():64-73. PubMed ID: 30205233
[TBL] [Abstract][Full Text] [Related]
11. New insights into non-enzymatic glycation of human serum albumin biopolymer: A study to unveil its impaired structure and function.
Raghav A; Ahmad J; Alam K; Khan AU
Int J Biol Macromol; 2017 Aug; 101():84-99. PubMed ID: 28322944
[TBL] [Abstract][Full Text] [Related]
12. Review: Glycation of human serum albumin.
Anguizola J; Matsuda R; Barnaby OS; Hoy KS; Wa C; DeBolt E; Koke M; Hage DS
Clin Chim Acta; 2013 Oct; 425():64-76. PubMed ID: 23891854
[TBL] [Abstract][Full Text] [Related]
13. Rosmarinic acid restrains protein glycation and aggregation in human serum albumin: Multi spectroscopic and microscopic insight - Possible Therapeutics Targeting Diseases.
Shamsi A; Ahmed A; Khan MS; Husain FM; Bano B
Int J Biol Macromol; 2020 Oct; 161():187-193. PubMed ID: 32526295
[TBL] [Abstract][Full Text] [Related]
14. Fructose-human serum albumin interaction undergoes numerous biophysical and biochemical changes before forming AGEs and aggregates.
Zaman A; Arif Z; Moinuddin ; Alam K
Int J Biol Macromol; 2018 Apr; 109():896-906. PubMed ID: 29133088
[TBL] [Abstract][Full Text] [Related]
15. Urolithin A alleviates advanced glycation end-product formation by altering protein structures, trapping methylglyoxal and forming complexes.
Peng CY; Zhu HD; Zhang L; Li XF; Zhou WN; Tu ZC
Food Funct; 2021 Nov; 12(23):11849-11861. PubMed ID: 34734623
[TBL] [Abstract][Full Text] [Related]
16. Preferential recognition of advanced glycation end products by serum antibodies and low-grade systemic inflammation in diabetes mellitus and its complications.
Raghav A; Ahmad J; Alam K
Int J Biol Macromol; 2018 Oct; 118(Pt B):1884-1891. PubMed ID: 30009900
[TBL] [Abstract][Full Text] [Related]
17. Glyburide inhibits non-enzymatic glycation of HSA: An approach for the management of AGEs associated diabetic complications.
Qais FA; Sarwar T; Ahmad I; Khan RA; Shahzad SA; Husain FM
Int J Biol Macromol; 2021 Feb; 169():143-152. PubMed ID: 33338529
[TBL] [Abstract][Full Text] [Related]
18. Protective actions of bioactive flavonoids chrysin and luteolin on the glyoxal induced formation of advanced glycation end products and aggregation of human serum albumin: In vitro and molecular docking analysis.
Sarmah S; Das S; Roy AS
Int J Biol Macromol; 2020 Dec; 165(Pt B):2275-2285. PubMed ID: 33058977
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D attenuates human gingival fibroblast inflammatory cytokine production following advanced glycation end product interaction with receptors for AGE.
Elenkova M; Tipton DA; Karydis A; Stein SH
J Periodontal Res; 2019 Apr; 54(2):154-163. PubMed ID: 30295316
[TBL] [Abstract][Full Text] [Related]
20. Calorimetric investigation of diclofenac drug binding to a panel of moderately glycated serum albumins.
Indurthi VS; Leclerc E; Vetter SW
Eur J Pharm Sci; 2014 Aug; 59():58-68. PubMed ID: 24751671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
